Concepedia

Christopher Morehouse

CM

Statistics

Publications

24

Citations

3K

H-Index

21

Active since

2000

Affiliations

AstraZeneca (United States)(Current)

Harvard University

Brigham and Women's Hospital

National Institutes of Health

Icahn School of Medicine at Mount Sinai

Christopher Morehouse is an author at AstraZeneca (United States) specializing in immunology, life sciences, and medicine.

Publications per year

2000–2023

24

Publications

24

IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE

Shu Wang, Jingya Wang, Varsha Kumar et al. · Nature Communications · 2018 · 569 citations · Full text

Life Sciences, Immunology, Nephrology +17

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang et al. · Cell · 2020 · 536 citations · Full text

Life Sciences, Immunology, Oncology +16

Patrolling Alveolar Macrophages Conceal Bacteria from the Immune System to Maintain Homeostasis

Arpan Sharma Neupane, Michelle Willson, Andrew Chojnacki et al. · Cell · 2020 · 344 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Neutralization of interferon‐α/β–inducible genes and downstream effect in a phase I trial of an anti–interferon‐α monoclonal antibody in systemic lupus erythematosus

Yihong Yao, Laura K. Richman, Brandon W. Higgs et al. · Arthritis & Rheumatism · 2009 · 279 citations

Life Sciences, Immunology, Pharmacology +17

Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab

Brandon W. Higgs, Christopher Morehouse, Katie Streicher et al. · Clinical Cancer Research · 2018 · 220 citations · Full text

Medicine, Molecular Medicine, Oncology +17

1–5 of 24